| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/16/2003 | WO2001087937A3 G-protein coupled receptors |
| 01/16/2003 | WO2001081375A9 Dna & protein binding miniature proteins |
| 01/16/2003 | WO2001068805A9 Human olfactory receptors and genes encoding same |
| 01/16/2003 | US20030013867 Translation enhancer element of the human amyloid precursor protein gene |
| 01/16/2003 | US20030013866 Eukaryotic cells expressing the receptor |
| 01/16/2003 | US20030013855 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013850 Antiinflammatory agents |
| 01/16/2003 | US20030013649 Hybrid polypeptide |
| 01/16/2003 | US20030013644 Complexing; therapy for genetic defects |
| 01/16/2003 | US20030013191 Transgenic cells for use in human therapeutics and diagnostics |
| 01/16/2003 | US20030013190 Altered strain of the modified vaccinia virus ankara (mva) |
| 01/16/2003 | US20030013181 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 01/16/2003 | US20030013157 Culturing cells which generate preferential immunoglobulins; obtain cell, transform cell, recover cell expressing preferential immunoglobulin, isolate immunoglobulin |
| 01/16/2003 | US20030013153 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013150 Methods for large scale protein production in prokaryotes |
| 01/16/2003 | US20030013149 Quantitative analysis |
| 01/16/2003 | US20030013131 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 01/16/2003 | US20030013108 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 01/16/2003 | US20030013081 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 01/16/2003 | US20030013077 Binding to monoclonal antibodies; detection of Kaposi's sarcoma |
| 01/16/2003 | US20030012848 Heating and maintaining an aqueous dispersion of a protein-containing starting material, while under an acidic condition, with a plate-type heat exchanger using a liquid as a heat medium to make the aqueous dispersion aseptic |
| 01/16/2003 | US20030012790 Especially bispecific molecules comprising an IFN- gamma inhibitor and a further specificity to a target involved in the initiation or development of IBD, including ulcerative colitis and Crohn's disease. |
| 01/16/2003 | US20030012787 Especially for ulcerative colitis and Crohn's disease. |
| 01/16/2003 | US20030012769 Wherein a part or all of a regulatory element of the U3 region of the 5' LTR is replaced by another regulatory element, operable in a mammalian cell, which is not endogenous to said lentivirus. |
| 01/16/2003 | CA2467006A1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | CA2453075A1 Drug metabolizing enzymes |
| 01/16/2003 | CA2453062A1 Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 01/16/2003 | CA2452849A1 Method for monitoring and modulating protein folding |
| 01/16/2003 | CA2452695A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | CA2452501A1 Secreted proteins |
| 01/16/2003 | CA2452396A1 Method of producing template dna and method of producing protein in cell-free protein synthesis system using the same |
| 01/16/2003 | CA2452359A1 Expression vectors encoding bacteriophage signal peptides |
| 01/16/2003 | CA2452241A1 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | CA2452119A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | CA2451395A1 Novel pgc-1 isoforms and uses therefor |
| 01/15/2003 | EP1275731A1 Method for preparing lipid II and use of the lipid II thus obtained |
| 01/15/2003 | EP1274849A2 Protein phosphatases |
| 01/15/2003 | EP1274846A2 Plastid transformation vectors for expressing human proteins in plants |
| 01/15/2003 | EP1274845A2 Lipid binding protein 3 |
| 01/15/2003 | EP1274844A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/15/2003 | EP1274843A1 New lipid binding protein 2 |
| 01/15/2003 | EP1274842A2 Lipid binding protein 4 |
| 01/15/2003 | EP1274841A2 Regulation of human cyslt2-like gpcr protein |
| 01/15/2003 | EP1274839A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 01/15/2003 | EP1274835A1 Human nim1 kinase |
| 01/15/2003 | EP1274730A2 Integrin/adhesion antagonists |
| 01/15/2003 | EP1274726A2 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 01/15/2003 | EP1274451A1 Sperm factor oscillogenin |
| 01/15/2003 | EP1274318A1 Cultured protein hydrolysate |
| 01/15/2003 | EP1274305A2 Aids ancestral viruses and vaccines |
| 01/15/2003 | EP0749981B1 Monoclonal antibody specific for pd-ecgf / thymidine phosphorylase |
| 01/15/2003 | EP0671927B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/15/2003 | CN1391614A Method for increasing yield of recombinant proteins in microbial fermentation processes |
| 01/15/2003 | CN1391610A BASB118 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391604A Medium for protein-free and serum-free cultivation of cells |
| 01/15/2003 | CN1391579A HEV antigenic peptide and its method |
| 01/15/2003 | CN1390852A Human auricular fibrillation pathogene and coding protein and its usage |
| 01/15/2003 | CN1390847A Salmon's calcitonin gene synthesized by plant preference codon and its application |
| 01/15/2003 | CN1098932C Method of synthesizing fluorescently labeled protein |
| 01/14/2003 | US6506893 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 01/14/2003 | US6506885 Monoclonal antibodies to the drug tilmicosin and a method for detecting the same |
| 01/14/2003 | US6506883 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 01/14/2003 | US6506881 Specific for human milk fat globule; complementarity determining region derived from variable domains of mouse monoclonal antibody |
| 01/14/2003 | US6506879 Endotoxin-free; genetically expressed in bacteria; atherosclerosis and cardiovascular disorder treatment |
| 01/14/2003 | US6506732 Utilization of whey protein hydrolysate as the active ingredient in skin care composition |
| 01/14/2003 | US6506598 Gene expression of tissue plasminogen activator in butyrate salt |
| 01/14/2003 | US6506591 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 01/14/2003 | US6506590 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 01/14/2003 | US6506589 Useful mutations of bacterial alkaline protease |
| 01/14/2003 | US6506586 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 01/14/2003 | US6506582 Extended by aspartic acid at 5' end and shortened at 3' end by one to eight amino acids; nonimmunogenic; binds CD4 lymphocytes |
| 01/14/2003 | US6506579 Increasing production of proteins in gram-positive microorganisms using SecG |
| 01/14/2003 | US6506578 Nucelotide encoding megakaryocytic protein tyrosine kinases |
| 01/14/2003 | US6506569 Drug screening; genetic engineering |
| 01/14/2003 | CA2194444C Immunomodulators |
| 01/14/2003 | CA2102595C Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 01/14/2003 | CA2027355C Yeast promoter |
| 01/10/2003 | CA2390522A1 Enzyme/tag binding and detection system |
| 01/09/2003 | WO2003003019A2 Process of purification of amyloid fibrils |
| 01/09/2003 | WO2003003010A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson’s disease |
| 01/09/2003 | WO2003002749A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 01/09/2003 | WO2003002736A2 A walk-through technique for in vitro recombination of polynucleotide sequences |
| 01/09/2003 | WO2003002713A2 Antibodies to opgl |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002609A2 Dual-specific ligand and its use |
| 01/09/2003 | WO2003002608A1 Humanized antibody against fibroblast growth factor-8 and fragment of the antibody |
| 01/09/2003 | WO2003002604A2 G protein coupled receptors and dna sequences thereof |
| 01/09/2003 | WO2003002144A1 Bispecific antibodies that bind to vegf receptors |
| 01/09/2003 | WO2003001985A2 Method for detection of melanoma |
| 01/09/2003 | WO2003001882A2 Putative neurotransmitter receptor (pnr) disruptions, compositions and methods relating thereto |
| 01/09/2003 | WO2003001870A2 Methods for making antibody fragments and compositions resulting therefrom |
| 01/09/2003 | WO2002077195A9 Plasmodium falciparum ama-1 protein and uses thereof |
| 01/09/2003 | WO2002074796A3 Histidine phosphatase interacting protein with 240kd |
| 01/09/2003 | WO2002048189A3 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 01/09/2003 | WO2002036625A3 Prokineticin polypeptides, related compositions and methods |
| 01/09/2003 | WO2002032953A3 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 01/09/2003 | WO2002032943A3 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 01/09/2003 | WO2002004518A3 Human neuropeptide y-like g protein-coupled receptor |
| 01/09/2003 | WO2001098351A3 G-protein coupled receptors |